Insider Trading History of Simon, Christopher

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Simon, Christopher since 2016. This trader's CIK number is 1674993. At the time of last reporting, Simon, Christopher was the President & CEO of Haemonetics Corp. (stock ticker symbol HAE). Also see all insider trading activities at Haemonetics Corp.


Yearly summary of insider trading at Haemonetics Corp (HAE) by Simon, Christopher

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 HAE 0 $0 0 $0 104,516 $4,352,046
2023 HAE 0 $0 0 $0 196,746 $5,629,886
2022 HAE 0 $0 6,972 $413,565 0 $0
2021 HAE 0 $0 5,895 $331,434 0 $0
2020 HAE 0 $0 56,029 $4,956,799 0 $0
2019 HAE 0 $0 141,958 $15,899,176 0 $0
2018 HAE 0 $0 10,675 $784,154 0 $0
2016 HAE 60,000 $2,099,760 0 $0 0 $0


Insider trading of Haemonetics Corp (HAE) by Simon, Christopher

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-06-06 HAE Option Ex 104,516 41.64 4,352,046
2023-06-29 HAE Option Ex 196,746 28.61 5,629,886
2022-06-13 HAE Sale 1,148 62.60 71,864
2022-05-19 HAE Sale 2,496 59.10 147,513
2022-05-19 HAE Sale 2,496 59.10 147,513
2022-05-16 HAE Sale 832 56.10 46,675
2021-06-14 HAE Sale 1,200 59.87 71,844
2021-06-07 HAE Sale 2,715 55.09 149,569
2021-05-19 HAE Sale 1,024 55.19 56,514
2021-05-17 HAE Sale 956 55.97 53,507
2020-06-30 HAE Sale 5,084 87.79 446,324
2020-06-12 HAE Sale 1,294 89.29 115,541
2020-06-15 HAE Sale 45,723 87.71 4,010,364
2020-06-08 HAE Sale 2,920 97.03 283,327
2020-05-15 HAE Sale 1,008 100.44 101,243
2019-08-19 HAE Sale 50,869 137.43 6,990,926
2019-07-01 HAE Sale 5,008 121.79 609,924
2019-06-12 HAE Sale 1,248 109.37 136,493
2019-06-07 HAE Sale 2,834 103.38 292,978
2019-05-23 HAE Sale 24,412 99.39 2,426,308
2019-05-13 HAE Sale 57,587 94.51 5,442,547
2018-07-02 HAE Sale 5,139 89.31 458,964
2018-06-07 HAE Sale 1,941 92.73 179,988
2017-06-29 HAE Sale 3,595 40.39 145,202
2016-08-04 HAE Buy 60,000 35.00 2,099,760

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Simon, Christopher (President & CEO of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.